RCUS

Arcus Biosciences Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth↓ 0/10
  • Value↓ 0/10
Arcus Biosciences sales and earnings growth
RCUS Growth
Low
  • Revenue Y/Y↑ 67.38%
  • EPS Y/Y↑ 23.87%
  • FCF Y/Y↓ -61.39%
Arcus Biosciences gross and profit margin trends
RCUS Profitability
Neutral
  • Gross margin ↑ 100.00%
  • EPS margin↓ -156.40%
  • ROIC 5Y↓ -37.23%
Arcus Biosciences net debt vs free cash flow
RCUS Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -35.9

Arcus Biosciences stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks